KLC1 Activators
Kinesin light chain 1 (KLC1) is a critical component of the kinesin-1 molecular motor complex, which is responsible for intracellular transport along microtubules in various cellular processes, including organelle trafficking, protein localization, and cell division. As a member of the kinesin family, KLC1 interacts with kinesin heavy chain (KHC) to form the functional kinesin-1 motor complex, facilitating cargo binding and transportation along microtubule tracks. KLC1 primarily functions as an adaptor protein, linking cargo molecules to the motor domain of KHC, thus allowing for the efficient and directed movement of cargo within the cell.
Activation of KLC1 is intricately linked to the activation of the kinesin-1 motor complex as a whole. One of the key mechanisms of KLC1 activation involves post-translational modifications such as phosphorylation, which regulate its interaction with KHC and cargo molecules. Phosphorylation of specific residues within KLC1 can modulate its binding affinity for KHC and cargo, thereby enhancing the efficiency of cargo transport. Additionally, various signaling pathways and cellular cues can regulate KLC1 activation by altering its subcellular localization or conformational dynamics. For instance, signaling molecules such as kinases or GTPases may directly phosphorylate KLC1 or indirectly regulate its activity by modulating the activity of upstream regulators. Moreover, cellular stimuli such as changes in calcium concentration or extracellular signals can trigger intracellular signaling cascades that ultimately impact KLC1 function and activation. Overall, the activation of KLC1 is a tightly regulated process that ensures proper intracellular transport and cellular homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $79.00 $321.00 $671.00 | 1 | |
Indirubin-3'-monoxime is a specific CDK5 activator that indirectly activates KLC1. By promoting CDK5 activity, it influences the phosphorylation status of KLC1 and modulates its association with kinesin heavy chain, ultimately enhancing intracellular transport along microtubules. This indirect activation suggests a regulatory role of CDK5 in KLC1-mediated processes, providing insights into potential strategies for enhancing intracellular trafficking events. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase (CDK) inhibitor that indirectly activates KLC1. By inhibiting CDKs, it influences the phosphorylation status of KLC1 and modulates its association with kinesin heavy chain, ultimately enhancing intracellular transport along microtubules. | ||||||
SC1 (Pluripotin) | 839707-37-8 | sc-255607 sc-255607A sc-255607B sc-255607C | 1 mg 5 mg 10 mg 25 mg | $167.00 $199.00 $473.00 $779.00 | ||
SC1 is a selective activator of AMP-activated protein kinase (AMPK), indirectly activating KLC1. By promoting AMPK activity, it influences the phosphorylation status of KLC1 and modulates its association with kinesin heavy chain, ultimately enhancing intracellular transport along microtubules. This indirect activation suggests a regulatory role of AMPK in KLC1-mediated processes, providing insights into potential strategies for enhancing intracellular trafficking events. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
Akt inhibitor VIII is an inhibitor of Akt, indirectly activating KLC1. By inhibiting Akt signaling, it disrupts the phosphorylation cascades that negatively regulate KLC1 activity, promoting its association with kinesin heavy chain and facilitating intracellular transport along microtubules. This indirect activation highlights the regulatory role of Akt in KLC1-mediated processes, offering a potential avenue for enhancing intracellular trafficking events. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a CDK inhibitor that indirectly activates KLC1. By inhibiting CDKs, it influences the phosphorylation status of KLC1 and modulates its association with kinesin heavy chain, ultimately enhancing intracellular transport along microtubules. This indirect activation suggests a regulatory role of CDKs in KLC1-mediated processes, providing insights into potential strategies for enhancing intracellular trafficking events. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Selumetinib is a selective MEK inhibitor that indirectly activates KLC1. By inhibiting MEK and suppressing the MAPK pathway, it modulates the phosphorylation status of KLC1 and facilitates its association with kinesin heavy chain, ultimately enhancing intracellular transport along microtubules. This indirect activation suggests a regulatory role of the MAPK pathway in KLC1-mediated processes, providing insights into potential strategies for enhancing intracellular trafficking events. | ||||||